1. Departments of Cytogenetics and Molecular Pathology, Legacy Health, Portland, OR;
2. Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;
3. Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA;
4. Laboratory Medicine Program, University Health Network and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada;
5. MDS Group, Microarrays Unit, Josep Carreras Leukaemia Research Institute, Barcelona, Spain;
6. Hematology Department University Hospital of Salamanca, IBSAL, Salamanca, Spain;
7. Laboratory of Cytogenetics and Molecular Cytogenetics, Department of Clinical Pathology, Italian Hospital, Buenos Aires, Argentina;
8. Hematology Laboratory, Germans Trias i Pujol University Hospital–Catalan Institute of Oncology, Josep Carreras Leukemia Research Institute, Barcelona, Spain;
9. Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany;
10. Department of Human Genetics, Hannover Medical School, Hannover, Germany;
11. Laboratory Genetics of Lymphoid Malignancies, Institute of Experimental Medicine, Buenos Aires, Argentina;
12. Laboratory of Cytogenetics and Molecular Medicine, Hematology University of Perugia, Perugia, Italy;
13. Department of Medicine, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY;
14. Department of Pathology, Massachusetts General Hospital, Boston, MA; and
15. College of Physicians and Surgeons, Columbia University Medical Center and the New York Presbyterian Hospital, New York, NY